Agilent Expands Presence in Colorado
Agilent Technologies has acquired 20 acres of land in Weld County, Colorado, USA, on which to build a pharmaceutical manufacturing facility.
Agilent Technologies (Santa Clara, California, USA) has acquired 20 acres of land in Weld County, Colorado, USA, on which to build a pharmaceutical manufacturing facility.
The expansion will enable the company to more than double its commercial manufacturing capacity for nucleic acid active pharmaceutical ingredients.
“The products manufactured at this site will be used by our customers to improve the lives of patients suffering from a variety of diseases,” said Skip Thune, general manager of the company’s Nucleic Acids Solutions Division. “At Agilent, we are committed to meeting the everâincreasing needs of our customers for oligonucleotides.”
Thune also noted that the expansion would result in about 150 to 200 new jobs.
“Colorado is thrilled to welcome Agilent Technologies to the state,” said Governor John Hickenlooper. “This expansion will enhance Colorado’s skilled workforce and dedication to research and development firms. We look forward to supporting Agilent’s innovative work in our state.”
For more information please visit: www.agilent.com
Top Execs from Agilent, Waters, and Bruker Take the Stage at J.P. Morgan Healthcare Conference
January 16th 2025The 43rd Annual Healthcare J.P. Morgan Healthcare Conference kicked off in San Francisco earlier this week. Here’s what top executives from Agilent, Bruker, and Waters, discussed during the event.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
SPE-Based Method for Detecting Harmful Textile Residues
January 14th 2025University of Valencia scientists recently developed a method using solid-phase extraction (SPE) followed by high-performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC–HRMS/MS) for detecting microplastics and other harmful substances in textiles.
